KDOQI Commentary on the KDIGO 2022 Update to the Clinical Practice Guideline for Diabetes Management in CKD

By sjmartinez • December 25, 2023

Mottl AK, Nicholas SB. KDOQI Commentary on the KDIGO 2022 Update to the Clinical Practice Guideline for Diabetes Management in CKD. Am J Kidney Dis. 2023 Dec 21:S0272-6386(23)00883-1. doi: 10.1053/j.ajkd.2023.09.003. Epub ahead of print. PMID: 38142396.

Tags: Chronic kidney disease, commentary, diabetes, evidence-based recommendation, GLP-1 RAs, guideline, guideline implementation, Nephrology, nephrology best practices, ns-MRAs, Publications, SGLT2 inhibitors

Advances in Biomarker Discovery for Cardiovascular Disease

Fu Q, Liu H. Advances in Biomarker Discovery for Cardiovascular Disease. Biomedicines. 2026 Sep 23;14(10):2144. doi: 10.3390/biomedicines14102144. PMID: 42939951; PMCID: PMC13701612.

Association of Estimated GFR at the Time of Peritoneal Dialysis Catheter Insertion With Dialysis-Related Complications

Dhoot A, Quinn RR, Clarke A, Armstrong S, Burdick R, Jain AK, Jassal SV, Kennealey PT, Liebman S, McCormick BB, Momciu B, Pauly RP, Perl[...]

Belimumab With Rituximab for the Treatment of Primary Membranous Nephropathy

Chung SA, Stelzig L, Sherman MA, Gao W, Tosta P, Cooney LA, Adler S, Aslam N, Ayoub I, Bomback AS, Coppock G, Derebail VK, Kamal[...]